In conclusion of our results, we expected GSK-3βto be the key regulator controlling the activity of eIF2Bε overexpression, since a loss of its phosphorylation site in eIF2Bε-S535A-TG animals lead to spontaneous cardiac hypertrophy. This evidence concerns the gene EIF2B5 and cardiac hypertrophy.